Related Experiment Videos
Hepatitis C. New guidelines on precautions, follow-up
Insights
Hepatitis C (HCV) poses a significant risk in operating rooms due to its prevalence and potential for lifelong infection, leading to serious liver complications. New CDC guidance offers support for healthcare workers facing HCV transmission concerns.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Context:
- Hepatitis C virus (HCV) infection is a significant concern in healthcare settings, particularly for operating room (OR) teams.
- A substantial number of individuals with HCV are asymptomatic, increasing the risk of undiagnosed transmission during surgical procedures.
- HCV affects an estimated 3.5 million people in the U.S., with a high rate of chronic infection.
Purpose:
- To highlight the increased risk of operating room teams encountering patients with Hepatitis C.
- To underscore the severe long-term health consequences of chronic HCV infection.
- To inform healthcare professionals about recent guidance addressing occupational concerns related to HCV.
Summary:
- Hepatitis C (HCV) is more prevalent among patients undergoing surgery than HIV or Hepatitis B.
- The majority of HCV infections become chronic, posing lifelong risks of cirrhosis and liver cancer.
- There is currently no vaccine for HCV, and treatment options are limited, complicating prevention efforts.
Impact:
- Increased awareness among healthcare providers regarding the risks associated with HCV in surgical environments.
- Emphasizes the need for improved screening and prevention strategies for Hepatitis C.
- Highlights the importance of updated guidelines from organizations like the CDC for managing occupational exposure risks.
Abstract:
An OR team has a greater chance of operating on a patient infected with hepatitis C than on a patient with HIV or hepatitis B. Many patients with HCV aren't critically ill, and the team may not know a patient is infected. HCV is more common than many think--an estimated 3.5 million people in the US are infected. The consequences are grave. For most, infection is lifelong. At least 85% become chronically infected. Chronically infected individuals are at risk for cirrhosis and liver cancer. Unfortunately, not much can be done to prevent transmission. There is no vaccine and not much in the way of treatment. In recent weeks, the Centers for Disease Control and Prevention (CDC) and professional societies have tried to address workers' concerns with new recommendations that, although they don't provide easy answers, offer added guidance.